Company profile: Ambu
1.1 - Company Overview
Company description
- Provider of medical devices across anaesthesia, patient monitoring & diagnostics, and emergency care. Founded in 1937, its products are relied on by millions of patients and healthcare professionals worldwide.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ambu
Immunostics
HQ: United States
Website
- Description: Provider of diagnostic solutions that assist in disease diagnosis, offering a compact automatic immunoassay analyzer, hemochroma PLUS hemoglobin/hematocrit device, hema-screen SPECIFIC GOLD colorectal cancer screening test, Swab-N-Go Home Test COVID-19 Ag with RAPIDCHECK app, Detector UA urine analysis strips, and Detector Strep A rapid test.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunostics company profile →
DIAsource Diagnostics
HQ: Belgium
Website
- Description: Provider of clinical diagnostic products and IVD solutions, developing, manufacturing, and marketing RIA and ELISA assays (manual and automated) for endocrinology, autoimmunity, and infectious diseases; monoclonal antibodies for in-vitro diagnostic assays; DIASpot immunodot platform for auto-immune testing; free 25OH Vitamin D assays; and the DIA5000 rapid test reader.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DIAsource Diagnostics company profile →
Cisbio
HQ: France
Website
- Description: Provider of bioassays and related products for neuroscience research and protein interaction studies, manufacturing SNAP-tag, CLIP-tag, and HaloTag specific substrates labeled with Lumi4-Terbium and green or red acceptor fluorophores, and offering a Glucagon kit for quantification of glucagon in cell culture.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cisbio company profile →
Hospitex
HQ: Italy
Website
- Description: Provider of cytology laboratory instruments and services, including CYTOfast Plus liquid-based cytology for thin-layer slides, CYTOfast Biobank for sample collection/preservation up to 8 weeks, BLOCKfast rapid cytoinclusion kit, CYTOfast Urine24 home urinary tract cancer screening, CYTOfast Vet24 veterinary thin-layer cytology with rapid reporting, and PapTest24 gynecological liquid-based cytology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hospitex company profile →
ProciseDx
HQ: United States
Website
- Description: Provider of point-of-care diagnostic solutions for physician offices, retail clinics, and urgent care, delivering rapid, lab-quality results. Offerings include tests for infliximab (Procise IFX), adalimumab (Procise ADL), C-reactive protein (Procise CRP), fecal calprotectin (Procise FCP), and the ProciseDx Instrument for quantitative immunoassays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProciseDx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ambu
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ambu
2.2 - Growth funds investing in similar companies to Ambu
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ambu
4.2 - Public trading comparable groups for Ambu
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →